Summit Trail Advisors LLC Has $1.48 Million Stake in Doximity, Inc. (NASDAQ:DOCS)

Summit Trail Advisors LLC reduced its holdings in Doximity, Inc. (NASDAQ:DOCS) by 0.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 52,932 shares of the company’s stock after selling 421 shares during the quarter. Summit Trail Advisors LLC’s holdings in Doximity were worth $1,484,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. Creative Financial Designs Inc. ADV boosted its position in Doximity by 16.7% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock valued at $93,000 after purchasing an additional 473 shares during the last quarter. Xponance Inc. raised its stake in shares of Doximity by 2.7% during the 3rd quarter. Xponance Inc. now owns 19,522 shares of the company’s stock worth $414,000 after purchasing an additional 508 shares in the last quarter. First Horizon Advisors Inc. grew its stake in shares of Doximity by 111.3% in the fourth quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock valued at $28,000 after buying an additional 524 shares in the last quarter. Ieq Capital LLC grew its stake in shares of Doximity by 0.6% in the third quarter. Ieq Capital LLC now owns 99,539 shares of the company’s stock valued at $2,112,000 after buying an additional 573 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC increased its holdings in Doximity by 2.0% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 40,758 shares of the company’s stock worth $1,143,000 after buying an additional 793 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Trading Up 2.1 %

Shares of DOCS traded up $0.51 on Monday, reaching $24.60. The company’s stock had a trading volume of 944,303 shares, compared to its average volume of 1,688,288. The stock has a market capitalization of $4.59 billion, a PE ratio of 37.27, a PEG ratio of 3.03 and a beta of 1.18. Doximity, Inc. has a twelve month low of $19.71 and a twelve month high of $36.29. The firm has a fifty day moving average of $26.45 and a 200-day moving average of $26.32.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings results on Thursday, February 8th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.06. Doximity had a return on equity of 16.08% and a net margin of 29.39%. The business had revenue of $135.28 million during the quarter, compared to the consensus estimate of $127.46 million. As a group, equities analysts anticipate that Doximity, Inc. will post 0.72 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently commented on DOCS. Leerink Partnrs reissued a “market perform” rating on shares of Doximity in a research report on Monday, February 26th. Evercore ISI reissued an “in-line” rating and set a $30.00 price target on shares of Doximity in a research report on Tuesday, April 2nd. JPMorgan Chase & Co. raised Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price objective for the company in a research report on Thursday, April 25th. Morgan Stanley reiterated an “underweight” rating and issued a $25.00 price target on shares of Doximity in a research report on Tuesday, April 23rd. Finally, Truist Financial increased their target price on shares of Doximity from $28.00 to $29.00 and gave the stock a “hold” rating in a report on Friday, February 9th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Doximity presently has an average rating of “Hold” and a consensus price target of $28.82.

Insider Buying and Selling at Doximity

In other news, Director Kira Scherer Wampler sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $26.97, for a total value of $67,425.00. Following the transaction, the director now owns 10,258 shares in the company, valued at $276,658.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 39.40% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.